190 related articles for article (PubMed ID: 20706716)
1. Integrating individual functional moieties of CXCL10 and CXCL11 into a novel chimeric chemokine leads to synergistic antitumor effects: a strategy for chemokine-based multi-target-directed cancer therapy.
Wang P; Yang X; Xu W; Li K; Chu Y; Xiong S
Cancer Immunol Immunother; 2010 Nov; 59(11):1715-26. PubMed ID: 20706716
[TBL] [Abstract][Full Text] [Related]
2. The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis.
Hensbergen PJ; Wijnands PG; Schreurs MW; Scheper RJ; Willemze R; Tensen CP
J Immunother; 2005; 28(4):343-51. PubMed ID: 16000952
[TBL] [Abstract][Full Text] [Related]
3. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection.
Meyer M; Hensbergen PJ; van der Raaij-Helmer EM; Brandacher G; Margreiter R; Heufler C; Koch F; Narumi S; Werner ER; Colvin R; Luster AD; Tensen CP; Werner-Felmayer G
Eur J Immunol; 2001 Aug; 31(8):2521-7. PubMed ID: 11500837
[TBL] [Abstract][Full Text] [Related]
4. Desiccating stress-induced chemokine expression in the epithelium is dependent on upregulation of NKG2D/RAE-1 and release of IFN-γ in experimental dry eye.
Coursey TG; Bohat R; Barbosa FL; Pflugfelder SC; de Paiva CS
J Immunol; 2014 Nov; 193(10):5264-72. PubMed ID: 25288568
[TBL] [Abstract][Full Text] [Related]
5. Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4
Hart M; Nickl L; Walch-Rueckheim B; Krammes L; Rheinheimer S; Diener C; Taenzer T; Kehl T; Sester M; Lenhof HP; Keller A; Meese E
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229509
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the chemokines I-TAC (CXCL11) and SDF-1 (CXCL12) in the regulation of tumor angiogenesis of colorectal cancer.
Rupertus K; Sinistra J; Scheuer C; Nickels RM; Schilling MK; Menger MD; Kollmar O
Clin Exp Metastasis; 2014 Apr; 31(4):447-59. PubMed ID: 24493023
[TBL] [Abstract][Full Text] [Related]
7. Differential Anti-Tumor Effects of IFN-Inducible Chemokines CXCL9, CXCL10, and CXCL11 on a Mouse Squamous Cell Carcinoma Cell Line.
Matsumoto A; Hiroi M; Mori K; Yamamoto N; Ohmori Y
Med Sci (Basel); 2023 Apr; 11(2):. PubMed ID: 37218983
[TBL] [Abstract][Full Text] [Related]
8. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.
Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Li K; Ross DJ; Strieter RM
J Immunol; 2002 Jul; 169(2):1037-49. PubMed ID: 12097412
[TBL] [Abstract][Full Text] [Related]
9. Interferon-inducible CXC chemokines directly contribute to host defense against inhalational anthrax in a murine model of infection.
Crawford MA; Burdick MD; Glomski IJ; Boyer AE; Barr JR; Mehrad B; Strieter RM; Hughes MA
PLoS Pathog; 2010 Nov; 6(11):e1001199. PubMed ID: 21124994
[TBL] [Abstract][Full Text] [Related]
10. Forced Expression of CXCL10 Prevents Liver Metastasis of Colon Carcinoma Cells by the Recruitment of Natural Killer Cells.
Kikuchi N; Ye J; Hirakawa J; Kawashima H
Biol Pharm Bull; 2019 Jan; 42(1):57-65. PubMed ID: 30381616
[TBL] [Abstract][Full Text] [Related]
11. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.
Tokunaga R; Zhang W; Naseem M; Puccini A; Berger MD; Soni S; McSkane M; Baba H; Lenz HJ
Cancer Treat Rev; 2018 Feb; 63():40-47. PubMed ID: 29207310
[TBL] [Abstract][Full Text] [Related]
12. Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with Cisplatin in solid tumors.
Li G; Tian L; Hou JM; Ding ZY; He QM; Feng P; Wen YJ; Xiao F; Yao B; Zhang R; Peng F; Jiang Y; Luo F; Zhao X; Zhang L; Zhou Q; Wei YQ
Clin Cancer Res; 2005 Jun; 11(11):4217-24. PubMed ID: 15930360
[TBL] [Abstract][Full Text] [Related]
13. Cancer-cell-secreted CXCL11 promoted CD8
Gao Q; Wang S; Chen X; Cheng S; Zhang Z; Li F; Huang L; Yang Y; Zhou B; Yue D; Wang D; Cao L; Maimela NR; Zhang B; Yu J; Wang L; Zhang Y
J Immunother Cancer; 2019 Feb; 7(1):42. PubMed ID: 30744691
[TBL] [Abstract][Full Text] [Related]
14. The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner.
Callahan V; Hawks S; Crawford MA; Lehman CW; Morrison HA; Ivester HM; Akhrymuk I; Boghdeh N; Flor R; Finkielstein CV; Allen IC; Weger-Lucarelli J; Duggal N; Hughes MA; Kehn-Hall K
Viruses; 2021 Jun; 13(6):. PubMed ID: 34205098
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms underlying the production of chemokine CXCL11 in the reaction of renal tubular epithelial cells with CD4
Wang X; Wang D; Wang X; Wang X; Sha JC; Gao Q
Transpl Immunol; 2021 Apr; 65():101337. PubMed ID: 32971208
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of antigen-specific CD8 T cell responses by co-delivery of Fc-fused CXCL11.
Namkoong H; Song MY; Seo YB; Choi DH; Kim SW; Im SJ; Sung YC; Park Y
Vaccine; 2014 Feb; 32(10):1205-12. PubMed ID: 23928465
[TBL] [Abstract][Full Text] [Related]
17. The murine chemokine CXCL11 (IFN-inducible T cell alpha chemoattractant) is an IFN-gamma- and lipopolysaccharide-inducible glucocorticoid-attenuated response gene expressed in lung and other tissues during endotoxemia.
Widney DP; Xia YR; Lusis AJ; Smith JB
J Immunol; 2000 Jun; 164(12):6322-31. PubMed ID: 10843686
[TBL] [Abstract][Full Text] [Related]
18.
Liang R; Li P; Yang N; Xiao X; Gong J; Zhang X; Bai Y; Chen Y; Xie Z; Liao Q
Drug Des Devel Ther; 2024; 18():1833-1853. PubMed ID: 38828018
[TBL] [Abstract][Full Text] [Related]
19. In situ expression of IFN-gamma-inducible T cell alpha chemoattractant in breast cancer mounts an enhanced specific anti-tumor immunity which leads to tumor regression.
Chu Y; Yang X; Xu W; Wang Y; Guo Q; Xiong S
Cancer Immunol Immunother; 2007 Oct; 56(10):1539-49. PubMed ID: 17659370
[TBL] [Abstract][Full Text] [Related]
20. [Expressions of CXCL9, CXCL10 and CXCL11 in renal tubular epithelial cells induced by IFN-γ].
Lin Q; Song Y; Zhu X; Yang S; Zheng J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):137-40. PubMed ID: 23388331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
